Andrew C. Weiss
Investor Relations Contact at IDORSIA LTD
Andrew C. Weiss active positions
| Companies | Position | Start | End |
|---|---|---|---|
| IDORSIA LTD | Investor Relations Contact | 2017-05-31 | - |
| Public Communications Contact | 2017-05-31 | - |
Career history of Andrew C. Weiss
Former positions of Andrew C. Weiss
| Companies | Position | Start | End |
|---|---|---|---|
| ACTELION | Investor Relations Contact | 2014-05-04 | 2016-12-31 |
| Public Communications Contact | 2014-05-04 | 2016-12-31 | |
| Bank Sarasin & Cie AG (Broker) | Analyst-Equity | - | 2007-04-30 |
| Julius Baer Holding AG | Corporate Officer/Principal | 1999-12-31 | 2004-12-31 |
| Bank Vontobel AG (Research Firm) | Analyst-Equity | - | - |
Training of Andrew C. Weiss
| University of Zurich | Graduate Degree |
Statistics
International
| Switzerland | 7 |
Operational
| Analyst-Equity | 2 |
| Investor Relations Contact | 2 |
| Public Communications Contact | 2 |
Sectoral
| Finance | 4 |
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| IDORSIA LTD | Health Technology |
| Private companies | 4 |
|---|---|
Actelion Ltd.
 Actelion Ltd. Pharmaceuticals: MajorHealth Technology Actelion Ltd. develops, produces and markets pharmaceutical drugs. The firm engages in research, development, manufacturing, and distribution of pharmaceutical, biological, and diagnostic products. The company was founded by Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Müller and Thomas Widmann on December 30, 1999 and is headquartered in Allschwil, Switzerland. | Health Technology |
| Bank Vontobel AG (Research Firm) | Finance |
| Bank Sarasin & Cie AG (Broker) | Finance |
| Julius Baer Holding AG | Finance |
- Stock Market
- Insiders
- Andrew C. Weiss
- Experience
